Investigation on the remission maintaining effect of Polaprezinc in patients with Crohn's disease in remission phase.
Not Applicable
Recruiting
- Conditions
- Patients with Crohn's disease in remission phase
- Registration Number
- JPRN-UMIN000005970
- Lead Sponsor
- Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who had undergone total parental nutrition. 2)Patients with serious liverdysfunction and renaldysfunction 3)Patients with serious heart disease ,lung disease and hemo? 4)Patients with malignancy 5)Patients who has a allergic history against Polaprezinc 6)Patients who are pregnant or have the possibility of pregnancy 7)The patient who was judged for unsuitable by responsibility doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Crohn's disease activity index at 0,1,3,6,12 months after treatment and 1 month after end point.
- Secondary Outcome Measures
Name Time Method Recurrence rate Evaluation of subjective symptoms QOL(F-8) safty change of labolatory data